News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,456 Results
Type
Article (15803)
Company Profile (42)
Press Release (247602)
Multimedia
Podcasts (5)
Webinars (1)
Section
Business (77582)
Career Advice (957)
Deals (14420)
Drug Delivery (24)
Drug Development (33581)
Employer Resources (24)
FDA (5393)
Job Trends (5606)
News (131538)
Policy (10435)
Tag
Academia (636)
Accelerated approval (4)
Adcomms (10)
Allergies (40)
Alliances (12602)
ALS (47)
Alzheimer's disease (483)
Antibody-drug conjugate (ADC) (58)
Approvals (5510)
Artificial intelligence (75)
Autoimmune disease (10)
Automation (6)
Bankruptcy (304)
Best Places to Work (4410)
BIOSECURE Act (6)
Biosimilars (45)
Biotechnology (31)
Bladder cancer (51)
Brain cancer (16)
Breast cancer (195)
Cancer (1412)
Cardiovascular disease (121)
Career advice (884)
Career pathing (4)
CAR-T (59)
CDC (2)
Cell therapy (171)
Cervical cancer (11)
Clinical research (29077)
Collaboration (277)
Company closure (2)
Compensation (211)
Complete response letters (12)
COVID-19 (867)
CRISPR (23)
C-suite (72)
Cystic fibrosis (43)
Data (1850)
Depression (29)
Diabetes (172)
Diagnostics (2105)
Digital health (7)
Diversity, equity & inclusion (4)
Drug discovery (45)
Drug pricing (21)
Drug shortages (5)
Duchenne muscular dystrophy (57)
Earnings (53373)
Editorial (12)
Employer branding (6)
Employer resources (19)
Events (45605)
Executive appointments (143)
FDA (6344)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (253)
Gene editing (42)
Generative AI (7)
Gene therapy (136)
GLP-1 (286)
Government (1312)
Grass and pollen (1)
Guidances (295)
Healthcare (6312)
HIV (18)
Huntington's disease (8)
IgA nephropathy (25)
Immunology and inflammation (66)
Immuno-oncology (4)
Indications (24)
Infectious disease (933)
Inflammatory bowel disease (46)
Inflation Reduction Act (1)
Influenza (22)
Intellectual property (37)
Interviews (184)
IPO (8271)
IRA (7)
Job creations (1424)
Job search strategy (675)
Kidney cancer (8)
Labor market (23)
Layoffs (153)
Leadership (3)
Legal (2122)
Liver cancer (32)
Longevity (2)
Lung cancer (238)
Lymphoma (121)
Machine learning (2)
Management (7)
Manufacturing (115)
MASH (48)
Medical device (4028)
Medtech (4033)
Mergers & acquisitions (6215)
Metabolic disorders (382)
Multiple sclerosis (38)
NASH (4)
Neurodegenerative disease (44)
Neuropsychiatric disorders (12)
Neuroscience (773)
NextGen: Class of 2025 (1619)
Non-profit (1123)
Now hiring (15)
Obesity (169)
Opinion (53)
Ovarian cancer (49)
Pain (50)
Pancreatic cancer (60)
Parkinson's disease (65)
Partnered (5)
Patents (90)
Patient recruitment (90)
Peanut (20)
People (11578)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase I (7707)
Phase II (12337)
Phase III (10792)
Pipeline (1561)
Policy (35)
Postmarket research (1440)
Preclinical (3243)
Press Release (14)
Prostate cancer (72)
Psychedelics (13)
Radiopharmaceuticals (103)
Rare diseases (209)
Real estate (1608)
Recruiting (11)
Regulatory (8051)
Reports (26)
Research institute (576)
Resumes & cover letters (122)
Rett syndrome (5)
RNA editing (2)
RSV (24)
Schizophrenia (58)
Series A (41)
Series B (30)
Service/supplier (5)
Sickle cell disease (27)
Special edition (12)
Spinal muscular atrophy (71)
Sponsored (5)
Startups (813)
Stomach cancer (7)
Supply chain (25)
Tariffs (11)
The Weekly (5)
Vaccines (302)
Venture capital (15)
Weight loss (112)
Women's health (11)
Worklife (1)
Date
Today (31)
Last 7 days (165)
Last 30 days (758)
Last 365 days (12567)
2025 (8413)
2024 (13978)
2023 (14738)
2022 (18194)
2021 (20284)
2020 (17574)
2019 (15072)
2018 (10206)
2017 (9427)
2016 (8467)
2015 (10689)
2014 (7582)
2013 (5571)
2012 (6068)
2011 (6746)
2010 (5751)
Location
Africa (262)
Alabama (20)
Alaska (1)
Arizona (81)
Arkansas (2)
Asia (15175)
Australia (2439)
California (3339)
Canada (998)
China (276)
Colorado (135)
Connecticut (174)
Delaware (110)
Europe (36404)
Florida (470)
Georgia (109)
Idaho (16)
Illinois (221)
India (13)
Indiana (182)
Iowa (1)
Japan (123)
Kansas (48)
Kentucky (14)
Louisiana (10)
Maine (41)
Maryland (390)
Massachusetts (2369)
Michigan (76)
Minnesota (190)
Mississippi (2)
Missouri (28)
Montana (9)
Nebraska (4)
Nevada (52)
New Hampshire (28)
New Jersey (1124)
New Mexico (7)
New York (908)
North Carolina (424)
North Dakota (3)
Northern California (1647)
Ohio (73)
Oklahoma (3)
Oregon (8)
Pennsylvania (727)
Puerto Rico (2)
Rhode Island (6)
South America (426)
South Carolina (5)
Southern California (1265)
Tennessee (31)
Texas (465)
United States (12017)
Utah (87)
Virginia (59)
Washington D.C. (15)
Washington State (300)
West Virginia (1)
Wisconsin (18)
263,456 Results for "11".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
11 Companies Hiring in California
Looking for a biopharma job in California? Check out the
BioSpace
list of 11 companies hiring life sciences professionals like you.
July 23, 2025
·
2 min read
·
Angela Gabriel
Job Trends
11 Companies Hiring Manufacturing Professionals
Looking for a manufacturing job? Check out the
BioSpace
list of 11 companies hiring life sciences professionals like you.
May 22, 2025
·
2 min read
·
Angela Gabriel
Obesity
Zealand’s GLP-1/GLP-2 Drug Elicits Over 11% Weight-Loss—With the Potential for More
Analysts at William Blair say dapiglutide’s 11.6% weight reduction at 28 weeks could still be better, given that Zealand’s study predominantly included men and enrolled patients with lower BMI at baseline.
June 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Senzime to Present at the European Growth Virtual Investor Conference on September 11
September 9, 2025
·
1 min read
Press Releases
Immunofluorescence Assay Market Size to Surpass USD 6.11 Billion by 2034
September 15, 2025
·
1 min read
Press Releases
iMDx to Participate in NYC Investment Conferences September 8 - 11
August 26, 2025
·
1 min read
Press Releases
SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025
September 12, 2025
·
2 min read
Press Releases
OS Therapies to Participate in Spotlight Panel at BioFuture 2025 October 13 11:00am EDT
September 19, 2025
·
5 min read
Obesity
Novo’s Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial
The sub-analysis, presented at the European Association for the Study of Diabetes congress, showed improved safety data to counteract past tolerability issues.
September 16, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025
September 4, 2025
·
1 min read
1 of 26,346
Next
